Management of Recurrent Retroperitoneal Sarcoma.
Curr Oncol
; 30(3): 2761-2769, 2023 02 25.
Article
in En
| MEDLINE
| ID: mdl-36975422
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retroperitoneal Neoplasms
/
Sarcoma
/
Soft Tissue Neoplasms
/
Leiomyosarcoma
/
Liposarcoma
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Curr Oncol
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Suiza